Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


03.12.2018

6 AIDS
2 AIDS Res Hum Retroviruses
1 BMC Pediatr
1 BMJ
2 Clin Infect Dis
3 HIV Med
2 J Clin Invest
1 J Infect Dis
3 J Virol
2 JAMA
4 Lancet
1 Lancet Glob Health
2 Lancet HIV
1 MMWR Morb Mortal Wkly Rep
18 PLoS One
2 PLoS Pathog
1 Proc Natl Acad Sci U S A
2 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. CYSIQUE LA, Juge L, Lennon MJ, Gates TM, et al
    HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection.
    AIDS. 2018 Nov 19. doi: 10.1097/QAD.0000000000002076.
    PubMed     Text format     Abstract available

  2. STEEN R, Hontelez JAC, Mugurungi O, Mpofu A, et al
    Economy, migrant labour and sex work - interplay of HIV epidemic drivers in Zimbabwe over three decades.
    AIDS. 2018 Nov 19. doi: 10.1097/QAD.0000000000002066.
    PubMed     Text format     Abstract available

  3. GNANASHANMUGAM D, Rakhmanina N, Crawford K, Nesheim S, et al
    Eliminating perinatal HIV in the United States: mission possible?
    AIDS. 2018 Nov 19. doi: 10.1097/QAD.0000000000002080.
    PubMed     Text format     Abstract available

  4. TIBUAKUU M, Fashanu OE, Zhao D, Otvos JD, et al
    GlycA, a novel inflammatory marker, is associated with subclinical coronary disease in the multicenter AIDS cohort study.
    AIDS. 2018 Nov 19. doi: 10.1097/QAD.0000000000002079.
    PubMed     Text format     Abstract available

  5. HILL KJ, Rogers LC, Njenda DT, Burke DH, et al
    Strain-specific effect on biphasic DNA binding by HIV-1 integrase.
    AIDS. 2018 Nov 19. doi: 10.1097/QAD.0000000000002078.
    PubMed     Text format     Abstract available

  6. LOAREC A, Carnimeo V, Molfino L, Kizito W, et al
    Extremely Low Hepatitis C prevalence among HIV co-infected individuals in 4 countries in sub-Saharan Africa.
    AIDS. 2018 Nov 16. doi: 10.1097/QAD.0000000000002070.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  7. BOMSEL M, Lopalco L, Uberti-Foppa C, Siracusano G, et al
    Decreased plasma calcitonin gene-related peptide (CGRP) as a novel biomarker for HIV-1 disease progression.
    AIDS Res Hum Retroviruses. 2018 Nov 29. doi: 10.1089/AID.2018.0210.
    PubMed     Text format     Abstract available

  8. HAO M, Wang J, He S, Hao Y, et al
    Identification of a Novel HIV-1 Second-generation Recombinant Form (CRF01_AE/07_BC) in Men Who Have Sex with Men in Beijing, China.
    AIDS Res Hum Retroviruses. 2018 Nov 29. doi: 10.1089/AID.2018.0228.
    PubMed     Text format     Abstract available


    BMC Pediatr

  9. HAYFRON-BENJAMIN A, Obiri-Yeboah D, Ayisi-Addo S, Siakwa PM, et al
    HIV diagnosis disclosure to infected children and adolescents; challenges of family caregivers in the Central Region of Ghana.
    BMC Pediatr. 2018;18:365.
    PubMed     Text format     Abstract available


    BMJ

  10. SIEDNER MJ, Tumarkin E, Bogoch II
    HIV post-exposure prophylaxis (PEP).
    BMJ. 2018;363:k4928.
    PubMed     Text format    


    Clin Infect Dis

  11. AKE JA, Polyak CS, Crowell TA, Kiweewa F, et al
    Noninfectious Comorbidity in the African Cohort Study (AFRICOS).
    Clin Infect Dis. 2018 Nov 26. pii: 5208355. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. DENNIS AM, Cohen MS, Rucinski KB, Rutstein SE, et al
    HIV-1 transmission among persons with acute HIV-1 infection in Malawi: demographic, behavioral and phylogenetic relationships.
    Clin Infect Dis. 2018 Nov 26. pii: 5208349. doi: 10.1093/cid/ciy1006.
    PubMed     Text format     Abstract available


    HIV Med

  13. KENDALL CE, Raboud J, Donelle J, Loutfy M, et al
    Lost but not forgotten: A population-based study of mortality and care trajectories among people living with HIV who are lost to follow-up in Ontario, Canada.
    HIV Med. 2018 Nov 26. doi: 10.1111/hiv.12682.
    PubMed     Text format     Abstract available

  14. PUHR R, Petoumenos K, Huang R, Templeton DJ, et al
    Cardiovascular disease and diabetes in HIV-positive and HIV-negative gay and bisexual men over the age of 55 years in Australia: insights from the Australian Positive & Peers Longevity Evaluation Study.
    HIV Med. 2018 Nov 26. doi: 10.1111/hiv.12689.
    PubMed     Text format     Abstract available

  15. TADESSE BT, Foster BA, Kabeta A, Ayalew F, et al
    Hepatic and renal toxicity and associated factors among HIV-infected children on antiretroviral therapy: a prospective cohort study.
    HIV Med. 2018 Nov 26. doi: 10.1111/hiv.12693.
    PubMed     Text format     Abstract available


    J Clin Invest

  16. FORTHAL D, Finzi A
    Blocking HIV-1 replication: are Fc-Fcgamma receptor interactions required?
    J Clin Invest. 2018 Nov 26. pii: 125264. doi: 10.1172/JCI125264.
    PubMed     Text format     Abstract available

  17. PARSONS MS, Lee WS, Kristensen AB, Amarasena T, et al
    Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques.
    J Clin Invest. 2018 Nov 26. pii: 122466. doi: 10.1172/JCI122466.
    PubMed     Text format     Abstract available


    J Infect Dis

  18. SUN J, Longchamps RJ, Piggott DA, Castellani CA, et al
    The association between HIV infection and mitochondrial DNA copy number in peripheral blood: a population-based, prospective cohort study.
    J Infect Dis. 2018 Nov 24. pii: 5204254. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  19. RINGE RP, Pugach P, Cottrell CA, LaBranche CC, et al
    Closing and opening holes in the glycan shield of HIV-1 envelope glycoprotein SOSIP trimers can redirect the neutralizing antibody response to the newly unmasked epitopes.
    J Virol. 2018 Nov 28. pii: JVI.01656-18. doi: 10.1128/JVI.01656.
    PubMed     Text format     Abstract available

  20. ROSAS-UMBERT M, Llano A, Bellido R, Olvera A, et al
    Mechanisms of abrupt loss of virus control in a cohort of previous HIV controllers.
    J Virol. 2018 Nov 28. pii: JVI.01436-18. doi: 10.1128/JVI.01436.
    PubMed     Text format     Abstract available

  21. ANGIUS F, Smuts H, Rybkina K, Stelitano D, et al
    Analysis of a subacute sclerosing panencephalitis (SSPE) Genotype B3 virus from the 2009/10 South African measles epidemic shows hyperfusogenic F proteins contribute to measles virus infection in the brain.
    J Virol. 2018 Nov 28. pii: JVI.01700-18. doi: 10.1128/JVI.01700.
    PubMed     Text format     Abstract available


    JAMA

  22. AMBROSIONI J, Mosquera M, Miro JM
    Baseline Genotype Testing to Assess Drug Resistance Before Beginning HIV Treatment.
    JAMA. 2018;320:2153-2154.
    PubMed     Text format    

  23. SAAG MS, Gunthard HF, Smith DM
    Baseline Genotype Testing to Assess Drug Resistance Before Beginning HIV Treatment-Reply.
    JAMA. 2018;320:2154.
    PubMed     Text format    


    Lancet


  24. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet. 2018;392:1684-1735.
    PubMed     Text format     Abstract available

  25. KIRBY T
    Susan Buchbinder: driving HIV prevention efforts worldwide.
    Lancet. 2018;392:2161.
    PubMed     Text format    

  26. HAAKENSTAD A, Moses M, Dieleman JL
    Comparing estimates of spending on health and HIV/AIDS - Authors' reply.
    Lancet. 2018;392:1622.
    PubMed     Text format    

  27. IZAZOLA-LICEA JA, Yakusik A, Mattur D
    Comparing estimates of spending on health and HIV/AIDS.
    Lancet. 2018;392:1621-1622.
    PubMed     Text format    


    Lancet Glob Health

  28. MCALLISTER DA, Liu L, Shi T, Chu Y, et al
    Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis.
    Lancet Glob Health. 2018 Nov 26. pii: S2214-109X(18)30408.
    PubMed     Text format     Abstract available


    Lancet HIV

  29. TIPPETT BARR BA, van Lettow M, van Oosterhout JJ, Landes M, et al
    National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis.
    Lancet HIV. 2018 Nov 19. pii: S2352-3018(18)30316.
    PubMed     Text format     Abstract available

  30. ROSENBERG NE, Pettifor AE
    Taking Malawi's option B+ programme from a B+ to an A.
    Lancet HIV. 2018 Nov 19. pii: S2352-3018(18)30320.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep


  31. World AIDS Day - December 1, 2018.
    MMWR Morb Mortal Wkly Rep. 2018;67:1305.
    PubMed     Text format     Abstract available


    PLoS One

  32. WEIR SS, Figueroa JP, Scott M, Byfield L, et al
    Reaching key populations through key venues: Insights from the Jamaica HIV Prevention Program.
    PLoS One. 2018;13:e0206962.
    PubMed     Text format     Abstract available

  33. VALADAO ALC, Pezzuto P, Silva VAO, Goncalves BS, et al
    Reactivation of latent HIV-1 in vitro using an ethanolic extract from Euphorbia umbellata (Euphorbiaceae) latex.
    PLoS One. 2018;13:e0207664.
    PubMed     Text format     Abstract available

  34. KAMTCHUM-TATUENE J, Al-Bayati Z, Mwandumba HC, Solomon T, et al
    Serum concentration of anti-Cytomegalovirus IgG and ischaemic stroke in patients with advanced HIV infection in Malawi.
    PLoS One. 2018;13:e0208040.
    PubMed     Text format     Abstract available

  35. CARY DC, Peterlin BM
    Procyanidin trimer C1 reactivates latent HIV as a triple combination therapy with kansui and JQ1.
    PLoS One. 2018;13:e0208055.
    PubMed     Text format     Abstract available

  36. CHIHANA ML, Huerga H, Van Cutsem G, Ellman T, et al
    Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries.
    PLoS One. 2018;13:e0207656.
    PubMed     Text format     Abstract available

  37. KHOZA MN, Delany-Moretlwe S, Scorgie F, Hove J, et al
    Men's perspectives on the impact of female-directed cash transfers on gender relations: Findings from the HPTN 068 qualitative study.
    PLoS One. 2018;13:e0207654.
    PubMed     Text format     Abstract available

  38. KAMBUTSE I, Igiraneza G, Ogbuagu O
    Perceptions of HIV transmission and pre-exposure prophylaxis among health care workers and community members in Rwanda.
    PLoS One. 2018;13:e0207650.
    PubMed     Text format     Abstract available

  39. TLOU B, Sartorius B, Tanser F
    Investigating risk factors for under-five mortality in an HIV hyper-endemic area of rural South Africa, from 2000-2014.
    PLoS One. 2018;13:e0207294.
    PubMed     Text format     Abstract available

  40. BJERREGAARD-ANDERSEN M, Lund N, Pinstrup Joergensen AS, Starup Jepsen F, et al
    Stillbirths in urban Guinea-Bissau: A hospital- and community-based study.
    PLoS One. 2018;13:e0197680.
    PubMed     Text format     Abstract available

  41. OVERHOLT L, Wohl DA, Fischer WA 2nd, Westreich D, et al
    Stigma and Ebola survivorship in Liberia: Results from a longitudinal cohort study.
    PLoS One. 2018;13:e0206595.
    PubMed     Text format     Abstract available

  42. BAK Y, Jun S, Choi JY, Lee Y, et al
    Altered intrinsic local activity and cognitive dysfunction in HIV patients: A resting-state fMRI study.
    PLoS One. 2018;13:e0207146.
    PubMed     Text format     Abstract available

  43. SHARIFI H, Mirzazadeh A, Shokoohi M, Karamouzian M, et al
    Estimation of HIV incidence and its trend in three key populations in Iran.
    PLoS One. 2018;13:e0207681.
    PubMed     Text format     Abstract available

  44. AUTENRIETH CS, Beck EJ, Stelzle D, Mallouris C, et al
    Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000-2020.
    PLoS One. 2018;13:e0207005.
    PubMed     Text format     Abstract available

  45. VIEGAS EO, Kroidl A, Munseri PJ, Missanga M, et al
    Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design.
    PLoS One. 2018;13:e0206838.
    PubMed     Text format     Abstract available

  46. CHOKO AT, Nanfuka M, Birungi J, Taasi G, et al
    A pilot trial of the peer-based distribution of HIV self-test kits among fishermen in Bulisa, Uganda.
    PLoS One. 2018;13:e0208191.
    PubMed     Text format     Abstract available

  47. TATEYAMA Y, Techasrivichien T, Musumari PM, Suguimoto SP, et al
    Obesity matters but is not perceived: A cross-sectional study on cardiovascular disease risk factors among a population-based probability sample in rural Zambia.
    PLoS One. 2018;13:e0208176.
    PubMed     Text format     Abstract available

  48. GRACE D, Gaspar M, Paquette R, Rosenes R, et al
    HIV-positive gay men's knowledge and perceptions of Human Papillomavirus (HPV) and HPV vaccination: A qualitative study.
    PLoS One. 2018;13:e0207953.
    PubMed     Text format     Abstract available

  49. KHAN B, Duncan I, Saad M, Schaefer D, et al
    Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experiment.
    PLoS One. 2018;13:e0206356.
    PubMed     Text format     Abstract available


    PLoS Pathog

  50. DICKS MDJ, Betancor G, Jimenez-Guardeno JM, Pessel-Vivares L, et al
    Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction.
    PLoS Pathog. 2018;14:e1007408.
    PubMed     Text format     Abstract available

  51. SIDDIQUI R, Suzu S, Ueno M, Nasser H, et al
    Apolipoprotein E is an HIV-1-inducible inhibitor of viral production and infectivity in macrophages.
    PLoS Pathog. 2018;14:e1007372.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  52. QU K, Glass B, Dolezal M, Schur FKM, et al
    Structure and architecture of immature and mature murine leukemia virus capsids.
    Proc Natl Acad Sci U S A. 2018 Nov 26. pii: 1811580115.
    PubMed     Text format     Abstract available


    Vaccine

  53. MCMORROW ML, Tempia S, Walaza S, Treurnicht FK, et al
    Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa.
    Vaccine. 2018 Nov 21. pii: S0264-410X(18)31573.
    PubMed     Text format     Abstract available

  54. KOCHHAR S, Excler JL, Bok K, Gurwith M, et al
    Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines.
    Vaccine. 2018 Nov 26. pii: S0264-410X(18)31235.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: